Cancer nanomedicine: progress, challenges and opportunities
This work was supported by the JSPS KAKENHI (JP17H03674, JP21H05047, JP20KK0341, JP20H03252, JP24H01286, and JP24K02024) (S.S.), JST CREST (JPMJCR1863 and JPMJCR24B3) (S.S.), JST CREST (JPMJCR24B3) (T.I.), JST CREST (JPMJCR24B3) (K.G.N.S.), Uehara Memorial Foundation (S.S.), Takeda Science Foundation (S.S.), the National Institute of Health (R35GM149329) (T.I.), the National Science Foundation (000819255) (T.I.), JST FOREST Program (JPMJFR2413) (T.N.), JSPS KAKENHI (JP17K07427, JP20K06625 and JP23H02476) (T.N.), and 2021 NAIST University Fellowships for the Creation of Innovation in Science and Technology (T.F.)
In this sense, in rat models of lung cancer (squamous cell carcinoma of the lung), high plasma levels of cadaverine were associated with disease progression [244], a finding that might indicate its roles not only as a biomarker but also as a causative agent for this specific tumor
doi: 10.1530/JOE-17-0278 66 TufailESanyalSMithalASanyalSChattopadhyayN
What This Means for You This interaction can increase the risk of side effects like diarrhea or allergic reactions